Positive 12-month Phase 2 data for NDV-01 in non-muscle invasive bladder cancer (NMIBC) demonstrated a 95% complete response (CR) rate at any time and a durable 76% CR rate at 12 months, with ...

Relmada Therapeutics (NASDAQ:RLMD) outlined progress on its lead urology oncology program and reviewed fourth-quarter results during its fourth quarter and full year 2025 earnings call, highlighting ...

Early data from the first phase III trial of Lilly’s triple agonist show reductions in weight and HbA1c for patients with type 2 diabetes.

New Taipei City’s Sanying MRT Line and the eastern extension of the Tamsui-Xinyi Line (Red Line) are scheduled to begin operations in June, the National Development Council (NDC) said yesterday. The ...

The New Taipei Metro's Sanyin Line and the eastern extension of the Taipei Metro's Tamsui-Xinyi Line (Red Line) are scheduled to begin operations in June, the National Development Council said today.

Miracle Trial Preliminary Blinded CRc Rate of 40% in First 30 Patients Suggests Encouraging Early Results in Relapsed/Refractory AMLHOUSTON, March 19, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., ...

Both have plenty to offer investors, but one has a better outlook.

Leads Genetics, a subsidiary of food company BL Agro, has announced that it has achieved 65 per cent success in its large-scale indigenous Cow Embryo Transfer programme, which is India’s first in ...

Kenya on Thursday restarted a multibillion‑dollar railway extension after a six‑year hiatus, reviving a project that stalled when funding ‌from China dried up and delayed plans to link the line to ...

Joining me on today’s call are Sean Nolan, Taysha Gene Therapies, Inc.'s Chief Executive Officer; Sukumar Nagendran, ...

BACKGROUND: Premature atrial contractions (PACs) are independently associated with atrial fibrillation, stroke, and heart failure, yet no pharmacological therapy is approved for PAC suppression.